{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T18:34:49Z","timestamp":1724178889138},"reference-count":50,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurologic Clinics"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.ncl.2018.03.001","type":"journal-article","created":{"date-parts":[[2018,4,11]],"date-time":"2018-04-11T18:14:58Z","timestamp":1523470498000},"page":"xiii-xvii","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Fifty Key Publications on Myasthenia Gravis and Related Disorders"],"prefix":"10.1016","volume":"36","author":[{"given":"Mazen M.","family":"Dimachkie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard J.","family":"Barohn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ncl.2018.03.001_bib1","series-title":"The London practice of physick, or the whole practical part of the physick contained in the works of Dr Willis","first-page":"431","author":"Willis","year":"1685"},{"key":"10.1016\/j.ncl.2018.03.001_bib2","first-page":"336","article-title":"Sur Casiusitik der bulb\u00e4ren L\u00e4hmungen","volume":"9","author":"Erb","year":"1879","journal-title":"Arch Psychiatr Nervenkr (1970)"},{"key":"10.1016\/j.ncl.2018.03.001_bib3","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/BF01665294","article-title":"Ueber einen scheinbar heilbaren bulb\u00e4rparlytischen Symptomencomplext mit Betheiligung der Extremit\u00e4ten","volume":"4","author":"Goldflam","year":"1893","journal-title":"Deitsche Zeitchrift f\u00fc r Nervenheilkndle"},{"key":"10.1016\/j.ncl.2018.03.001_bib4","series-title":"Die Myastenische Paralyse (Bulbarparalyse ohne anatomischen Befund)","author":"Oppenheim","year":"1901"},{"key":"10.1016\/j.ncl.2018.03.001_bib5","first-page":"1","article-title":"Ueber Myasthenia gravis pseudoparalytica","volume":"32","author":"Jolly","year":"1895","journal-title":"Berliner Klinische Wochenschrift"},{"key":"10.1016\/j.ncl.2018.03.001_bib6","first-page":"597","article-title":"Pathologisch-anatomischer Beitrag zur Erb\u2019schen Krankheit (Myasthenia gravis)","volume":"20","author":"Wiegert","year":"1901","journal-title":"Neurol Zentralblatt"},{"key":"10.1016\/j.ncl.2018.03.001_bib7","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/00005053-191702000-00002","article-title":"Tumors of the thymus in myasthenia gravis","volume":"45","author":"Bell","year":"1917","journal-title":"J\u00a0Nerv Ment Dis"},{"key":"10.1016\/j.ncl.2018.03.001_bib8","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1158\/ajc.1936.421","article-title":"The thymoma and thymic hyperplasia in myasthenia gravis with observations on the general pathology","volume":"27","author":"Norris","year":"1936","journal-title":"Am J Cancer"},{"key":"10.1016\/j.ncl.2018.03.001_bib9","first-page":"746","article-title":"Thymektomie bei einem Fall von Murbus Basedowi mit Myastenia","volume":"25","author":"Schumacher","year":"1913","journal-title":"Mittelungren aus den Grenzgebeiten der Medizin und Chirurrgi"},{"key":"10.1016\/j.ncl.2018.03.001_bib10","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1097\/00000658-193910000-00005","article-title":"Myasthenia gravis and tumors of the thymic region: report of a case in which the tumor was removed","volume":"110","author":"Blalock","year":"1939","journal-title":"Ann Surg"},{"key":"10.1016\/j.ncl.2018.03.001_bib11","first-page":"1529","article-title":"The treatment of myasthenia gravis by removal of the thymus gland","volume":"117","author":"Blalock","year":"1941","journal-title":"J\u00a0Am Med Assoc"},{"issue":"1","key":"10.1016\/j.ncl.2018.03.001_bib12","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1212\/WNL.55.1.7","article-title":"Practice parameter: thymectomy for autoimmune myasthenia gravis (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology","volume":"55","author":"Gronseth","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2018.03.001_bib13","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/S0140-6736(00)94294-6","article-title":"Treatment of myasthenia gravis with physostigmine","volume":"1","author":"Walker","year":"1934","journal-title":"Lancet"},{"key":"10.1016\/j.ncl.2018.03.001_bib14","first-page":"759","article-title":"Case showing the effect of prostigmin on myasthenia gravis","volume":"28","author":"Walker","year":"1935","journal-title":"Proc R Soc Med"},{"issue":"11","key":"10.1016\/j.ncl.2018.03.001_bib15","first-page":"961","article-title":"Studies in myasthenia gravis; preliminary report on therapy with mestinon bromide","volume":"155","author":"Osserman","year":"1954","journal-title":"J\u00a0Am Med Assoc"},{"issue":"7","key":"10.1016\/j.ncl.2018.03.001_bib16","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1056\/NEJM195408122510706","article-title":"Pyridostigmin (mestinon) in the treatment of myasthenia gravis","volume":"251","author":"Schwab","year":"1954","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ncl.2018.03.001_bib17","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1212\/WNL.22.1.71","article-title":"Histometric study of neuromuscular junction ultrastructure I. Myasthenia gravis","volume":"22","author":"Santa","year":"1972","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2018.03.001_bib18","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1126\/science.180.4088.871","article-title":"Autoimmune response to acetylcholine receptor","volume":"180","author":"Patrick","year":"1973","journal-title":"Science"},{"key":"10.1016\/j.ncl.2018.03.001_bib19","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1056\/NEJM197510092931508","article-title":"Acetylcholine receptor antibodies in myasthenia gravis","volume":"293","author":"Appel","year":"1975","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ncl.2018.03.001_bib20","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1212\/WNL.26.11.1054","article-title":"Antibody to acetylcholine receptor in myasthenia gravis","volume":"26","author":"Lindstrom","year":"1976","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2018.03.001_bib21","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0140-6736(75)91886-3","article-title":"Myasthenia gravis: a serum factor blocking acetylcholine receptors of the human neuromuscular junction","volume":"1","author":"Bender","year":"1975","journal-title":"Lancet"},{"key":"10.1016\/j.ncl.2018.03.001_bib22","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJM197701202960301","article-title":"Study of humoral immune mechanisms by passive transfer to mice","volume":"296","author":"Tokya","year":"1977","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ncl.2018.03.001_bib23","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1056\/NEJM197201062860104","article-title":"Benefit from alternate-day prednisone in myasthenia gravis","volume":"286","author":"Warmolts","year":"1972","journal-title":"N\u00a0Engl J Med"},{"issue":"7754","key":"10.1016\/j.ncl.2018.03.001_bib24","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0140-6736(72)90520-X","article-title":"Treatment of myasthenia gravis with prednisone","volume":"1","author":"Jenkins","year":"1972","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ncl.2018.03.001_bib25","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/ana.410150316","article-title":"Long-term corticosteroid treatment of myasthenia gravis: report of 116 patients","volume":"15","author":"Pascuzzi","year":"1984","journal-title":"Ann Neurol"},{"issue":"8000","key":"10.1016\/j.ncl.2018.03.001_bib26","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/S0140-6736(76)91917-6","article-title":"Remission of myasthenia gravis following plasma-exchange","volume":"2","author":"Pinching","year":"1976","journal-title":"Lancet"},{"issue":"21","key":"10.1016\/j.ncl.2018.03.001_bib27","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1056\/NEJM197711242972102","article-title":"Plasmapheresis and immunosuppressive drug therapy in myasthenia gravis","volume":"297","author":"Dau","year":"1977","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1016\/j.ncl.2018.03.001_bib28","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1056\/NEJM198703193161205","article-title":"Preliminary results of a double-blind, randomized, placebo-controlled trial of cyclosporine in myasthenia gravis","volume":"316","author":"Tindall","year":"1987","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ncl.2018.03.001_bib29","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1749-6632.1993.tb22937.x","article-title":"A\u00a0clinical therapeutic trial of cyclosporine in myasthenia gravis","volume":"681","author":"Tindall","year":"1993","journal-title":"Ann N Y Acad Sci"},{"issue":"6","key":"10.1016\/j.ncl.2018.03.001_bib30","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1212\/WNL.50.6.1778","article-title":"A\u00a0randomized double-blind trial of prednisolone alone or with azathioprine in myasthenia gravis. Myasthenia Gravis Study Group","volume":"50","author":"Palace","year":"1998","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.ncl.2018.03.001_bib31","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1212\/01.wnl.0000256698.69121.45","article-title":"IV immunoglobulin in patients with myasthenia gravis: a randomized controlled trial","volume":"68","author":"Zinman","year":"2007","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.ncl.2018.03.001_bib32","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/0013-4694(69)90066-2","article-title":"The effect of non-paralytic doses of D-tubocurarine on individual motor end-plates in man, studied with a new electrophysiological method","volume":"27","author":"Ekstedt","year":"1969","journal-title":"Electroencephalogr Clin Neurophysiol"},{"key":"10.1016\/j.ncl.2018.03.001_bib33","first-page":"612","article-title":"Defect of neuromuscular conduction associated with malignant neoplasms","volume":"187","author":"Lambert","year":"1956","journal-title":"Am J Physiol"},{"issue":"4","key":"10.1016\/j.ncl.2018.03.001_bib34","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/ana.410010403","article-title":"A\u00a0new myasthenic syndrome with end-plate acetylcholinesterase deficiency, small nerve terminals, and reduced acetylcholine release","volume":"1","author":"Engel","year":"1977","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ncl.2018.03.001_bib35","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/S0025-6196(12)65705-X","article-title":"Antibodies bind solubilized calcium channel-omega-conotoxin complexes from small cell lung carcinoma: a diagnostic aid for Lambert-Eaton myasthenic syndrome","volume":"64","author":"Lennon","year":"1989","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.ncl.2018.03.001_bib36","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/85520","article-title":"Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies","volume":"7","author":"Hoch","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.ncl.2018.03.001_bib37","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1001\/archneurol.2011.2393","article-title":"Autoantibodies to lipoprotein-related protein 4 in patients with double-seronegative myasthenia gravis","volume":"69","author":"Zhang","year":"2012","journal-title":"Arch Neurol"},{"issue":"1","key":"10.1016\/j.ncl.2018.03.001_bib38","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1212\/WNL.55.1.16","article-title":"Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America","volume":"55","author":"Jaretzki","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2018.03.001_bib39","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1111\/j.1749-6632.1998.tb11015.x","article-title":"Reliability testing of the quantitative myasthenia gravis score","volume":"841","author":"Barohn","year":"1998","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.ncl.2018.03.001_bib40","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1212\/WNL.52.7.1487","article-title":"Myasthenia gravis activities of daily living profile","volume":"52","author":"Wolfe","year":"1999","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.ncl.2018.03.001_bib41","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1002\/mus.21053","article-title":"The Muscle Study Group. Less is more, or almost as much: a 15-item quality-of-life instrument for myasthenia gravis","volume":"38","author":"Burns","year":"2008","journal-title":"Muscle Nerve"},{"issue":"9","key":"10.1016\/j.ncl.2018.03.001_bib42","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1212\/WNL.0000000000002971","article-title":"Development and validation of the myasthenia gravis impairment index","volume":"87","author":"Barnett","year":"2016","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.ncl.2018.03.001_bib43","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1056\/NEJMoa1602489","article-title":"Randomized trial of thymectomy in myasthenia gravis","volume":"375","author":"Wolfe","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.ncl.2018.03.001_bib44","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/mus.23839","article-title":"A\u00a0randomized, double-blind, placebo-controlled phase II study of eculizumab in patients with refractory generalized myasthenia gravis","volume":"48","author":"Howard","year":"2013","journal-title":"Muscle Nerve"},{"issue":"12","key":"10.1016\/j.ncl.2018.03.001_bib45","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/S1474-4422(17)30369-1","article-title":"Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study","volume":"16","author":"Howard","year":"2017","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ncl.2018.03.001_bib46","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3181\/00379727-105-26050","article-title":"Changes in serum complement activity in patients with myasthenia gravis","volume":"105","author":"Nastuk","year":"1960","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1016\/j.ncl.2018.03.001_bib47","first-page":"627","article-title":"Immune complexes (IgG and C3) at the motor end-plate in myasthenia gravis: ultrastructural and light microscopic localization and electrophysiologic correlations","volume":"52","author":"Engel","year":"1977","journal-title":"Mayo Clin Proc"},{"issue":"6","key":"10.1016\/j.ncl.2018.03.001_bib48","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1212\/01.wnl.0000312373.67493.7f","article-title":"A\u00a0trial of mycophenolate mofetil with prednisone as initial immunotherapy myasthenia gravis","volume":"71","year":"2008","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.ncl.2018.03.001_bib49","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1212\/01.wnl.0000312374.95186.cc","article-title":"An international, phase III, randomized trial of mycophenolate mofetil in myasthenia gravis","volume":"71","author":"Sanders","year":"2008","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.ncl.2018.03.001_bib50","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1212\/WNL.0000000000002795","article-title":"A\u00a0randomized controlled trial of methotrexate for patients with generalized myasthenia gravis","volume":"87","author":"Pasnoor","year":"2016","journal-title":"Neurology"}],"container-title":["Neurologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733861918300124?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733861918300124?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,22]],"date-time":"2018-08-22T10:29:47Z","timestamp":1534933787000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733861918300124"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S0733861918300124"],"URL":"https:\/\/doi.org\/10.1016\/j.ncl.2018.03.001","relation":{},"ISSN":["0733-8619"],"issn-type":[{"value":"0733-8619","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fifty Key Publications on Myasthenia Gravis and Related Disorders","name":"articletitle","label":"Article Title"},{"value":"Neurologic Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ncl.2018.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}